Revenue Update on SunLink Health Systems(NYSEMKT:SSY)

SunLink Health Systems(NYSEMKT:SSY) announced the earnings results for Fiscal Year 2017 and Q2. The results came in during After-Market on Feb 14, 2017. Based on the corporate Earnings and Guidance, many Investment Banking firms balance their portfolio to Sell and Buy Stocks based on their strategy of investing in stocks.Earnings per share were $0.02.

SunLink Health Systems (SSY) shares turned negative on Wednesdays trading session with the shares closing down -0.02 points or -1.18% at a volume of 33,419. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $1.68. The peak price level was also seen at $1.68 while the days lowest was $1.6. Finally the shares closed at $1.67. The 52-week high of the shares is $1.9 while the 52-week low is $0.359. According to the latest information available, the market cap of the company is $16 M.

Several Insider Transactions has been reported to the SEC. On Oct 13, 2016, Karen B Brenner (director) sold 8,320 shares at $0.88 per share price.Also, On Oct 16, 2015, Steven J Baileys (director) sold 2,676 shares at $1.72 per share price.On Aug 6, 2015, Robert M Jr Thornton (CEO) purchased 10,000 shares at $0.53 per share price, according to the Form-4 filing with the securities and exchange commission.

SunLink Health Systems Inc. owns businesses which provides healthcare services in various markets in the United States. The Company operates through two segments: the Healthcare Facilities Segment and the Specialty Pharmacy Segment. The Company’s Healthcare Facilities Segment operates around three operational areas such as three community hospitals in two states having approximately 183 beds each of which is owned by the Company’s subsidiary; around two nursing homes with approximately 166 beds each of which is owned by a hospital subsidiary and located adjacent to corresponding community hospital and a healthcare facility which is vacant except for two offices rented to a physician and a testing lab. The Company’s Specialty Pharmacy Segment operates around four operational areas such as retail pharmacy products and services all of which are conducted in rural markets; institutional pharmacy services; specialty pharmacy services and durable medical equipment.

Add Comment